|
|
| originated 2006/USA updated January 2010
a global non profit women’s health initiative
Estrogen Matters is an online sanctuary for women to nurture their menopause and post menopausal health through self care and disease prevention.
Site Map
Actonel, Boniva and Fosamax how do they effect bone? Fosamax, Actonel and Boniva are antiresorptive prescription medications that inhibit the breakdown of bone. Below is an overview of how these bisphosphonates reduce postmenopausal bone loss. The predominant mineral elements in bone matrix are crystals of calcium and phosphate, known as hydroxyapatite crystals. These tiny crystals lie in and around the collagen fibers and account for bones hardness, which allows it to resist shattering or compression. Hydroxyapatite crystals are essential for the structural strength of bone.
Bisphosphonates more commonly known as Fosamax (alendronate), Boniva (ibandronate), and Actonel (risedronate), are prescription anti-resorptive agents that bind permanently to the hydroxyapatite crystalline structure in bone. Bisphosphonates are ca-apatite loving, bone binding analogs of pyrophosphate in which the oxygen has been replaced by a carbon atom. As a result of this chemical structure bisphosphonates will not break down.
Bisphosphonates attach to osteoclast bone digesting sites and halt osteoclast activity. Bisphosphonates reduce osteoclast bone resorption, which in turn maintains bone mineral density. Specifically, bisphosphonates inhibit the breakdown of bone. As such, bisphosphonates reduce or even stopped bone loss.
|
 | Osteoporosis is a condition in which bone breakdown outpaces bone formation
resulting in porous fragile bone.
Porous fragile bone increases the likelihood of bone fracture. A fracture is often the first sign of osteoporosis. By the time a fracture occurs, the osteoporosis is usually advanced and the women is then susceptible to more fractures.
|
| | Trabecular bone is the spongy interior within bone. Trabecular bone serves most of the metabolic function of bone. As such, trabecular bone has a higher number of active remodeling sites than the outer cortical bone. Bisphosphonates prevent resorption and increase the strength of trabecular rich bones such as the spine (vertebrae) and hip (femoral trochanter).
Bisphosphonates reduce fracture rates by prolonging secondary mineralization. Essentially, bisphosphonates harden the remaining bone and increase bone mineralization density and therefore strength. They do so without effecting trabecular thickness or number, i.e. without increasing the amount of bone tissue. This helps explain why anti-resorptive agents reduce fracture risk, even in the absence of substantial increases in bone mineral density. The indication of treatment success when using bisphosphonate therapy is the absence of bone loss, not the extent of bone gain.
Diminished post menopausal estrogen decreases the activity of of osteoblasts and reduces the number of osteocytes. Bisphosphonates have a positive effect on osteoblasts and osteocytes by protecting these bone generating cells from self destruction (apoptotic). Osteoblasts are bone forming cells. Enabling osteoblasts to live longer improves the ability of these bone forming cells to repair micro cracks.
Osteocytes are mature bone cells located deep within bone. Osteocytes receive nutrients and function to maintain the bone matrix. If osteocytes die, the surrounding bone matrix is resorbed. Osteocytes also detect bone micro-damage and transmit signals leading to bone repair. Disruption of the osteocyte network would weaken this signaling mechanism, leading to micro-crack accumulation and increased bone fragility.
Bisphosphonates reduce bone fracture by preserving bone, maintaining osteocytes and prolonging the working time of bone forming osteoblast cells. Preventing bone resorption (withdrawl) reduces bone fracture.
Noteworthy: Calcium supplementation improves the efficacy of hormone replacement therapy, selective estrogen receptor modulators and bisphosphonates in reducing postmenopausal bone loss.
Source:
Mechanisms of Action of Antiresorptive Therapies of Postmenopausal Osteoporosis
J.J. Stepan MD
Endocrine Regulations, VOL, 37, 227-240, 2003
|
compassion Your $10 donation will help women like you make informed health decisions and expand the global outreach of this online clinic. Thank You !
All donations are securely processed through PayPal. CardioE2 Medical Communications
 Osteoblasts, Osteoclasts and Osteocytes are specialized cells that are necessary for the metabolic activities of bone.
Osteoblasts are bone forming cells.
Osteoclasts are cells that resorb or breakdown bone.
Osteocytes are mature bone cells that maintain bone. Resorption is a process when old bone is dissolved.
It is estimated that half of American women over age fifty will have an osteoporosis related fracture in their lifetime. | 
There are two major types of bone: cortical and trabecular.
Cortical bone makes up
the smooth white outer bone.
Cortical bone serves as the mechanical and protective functions of the skeleton.
Trabecular bone is the interior within cortical bone.
Trabecular bone has the appearance of a porous sponge and is comprised of
a network of vertical and horizontal free formed interlaced columns.
Trabecular bone serves most of
the metabolic functions of the skeleton.
|
for an overview regarding how nutrition helps prevent and manage osteoporosis click here |
CardioE2 . . . For Her Heart, Inc is a nonprofit organization # 900000216 registered and based in Florida, USA "Ownership and Rights. CardioE2 . . . For Her Heart Inc., the parent of Vascular Events shall own all and exclusive right, title, and interest in the work throughout the world, including copyrights, domain names, trademarks, and all other intellectual property rights in the work. The work shall be deemed to be a work-for-hire under the Copyright Act of 1976, Title 17 U.S.Code, and CardioE2 . . . Ann Williams., shall be deemed to be the author.” Information is provided for educational purposes to help individuals form an understanding of biological processes as they effect health. This information is not intended for medical diagnosis or treatment. |
email EstrogenMatters@msn.com
| |
|
|